Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (141-150 of 395) with videos related to

Pageof 40
Sort By:
Journal of Clinical Immunology|August 15, 2015
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical ResponseRossella Talotta, Angela Berzi, Fabiola Atzeni, et al.
Current Vascular Pharmacology|January 28, 2020
Cardiovascular Consequences of Autoimmune Rheumatic DiseasesFabiola Atzeni, Valeria Nucera, Elisabetta Gerratana, et al.
Clinical and Experimental Rheumatology|December 25, 2012
Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorderAlessandra Alciati, Piercarlo Sarzi-Puttini, Alberto Batticciotto, et al.
Autoimmunity Reviews|November 8, 2017
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?Andrea Rubbert-Roth, Fabiola Atzeni, Ignazio Francesco Masala, et al.
Autoimmunity|January 8, 2008
Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-upFabiola Atzeni, Andrea Doria, Anna Ghirardello, et al.
Autoimmunity|January 8, 2008
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical valueFabiola Atzeni, Andrea Doria, Anna Ghirardello, et al.
Internal and Emergency Medicine|October 20, 2011
Cardiovascular injury in systemic autoimmune diseases: an updateMaurizio Turiel, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Best Practice & Research. Clinical Rheumatology|August 13, 2015
Pain in systemic inflammatory rheumatic diseasesFabiola Atzeni, Ignazio Francesco Masala, Fausto Salaffi, et al.
Expert Review of Clinical Pharmacology|January 23, 2016
Novel pharmaceutical options for treating fibromyalgiaMaria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, et al.
Annals of the Rheumatic Diseases|November 10, 2022
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunitiesAlvise Berti, Fabiola Atzeni, Lorenzo Dagna, et al.
Pageof 40

Showing results (141-150 of 395) with videos related to

Sort By:
Pageof 40
Journal of Clinical Immunology|August 15, 2015
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical ResponseRossella Talotta, Angela Berzi, Fabiola Atzeni, et al.
Current Vascular Pharmacology|January 28, 2020
Cardiovascular Consequences of Autoimmune Rheumatic DiseasesFabiola Atzeni, Valeria Nucera, Elisabetta Gerratana, et al.
Clinical and Experimental Rheumatology|December 25, 2012
Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorderAlessandra Alciati, Piercarlo Sarzi-Puttini, Alberto Batticciotto, et al.
Autoimmunity Reviews|November 8, 2017
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?Andrea Rubbert-Roth, Fabiola Atzeni, Ignazio Francesco Masala, et al.
Autoimmunity|January 8, 2008
Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-upFabiola Atzeni, Andrea Doria, Anna Ghirardello, et al.
Autoimmunity|January 8, 2008
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical valueFabiola Atzeni, Andrea Doria, Anna Ghirardello, et al.
Internal and Emergency Medicine|October 20, 2011
Cardiovascular injury in systemic autoimmune diseases: an updateMaurizio Turiel, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Best Practice & Research. Clinical Rheumatology|August 13, 2015
Pain in systemic inflammatory rheumatic diseasesFabiola Atzeni, Ignazio Francesco Masala, Fausto Salaffi, et al.
Expert Review of Clinical Pharmacology|January 23, 2016
Novel pharmaceutical options for treating fibromyalgiaMaria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, et al.
Annals of the Rheumatic Diseases|November 10, 2022
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunitiesAlvise Berti, Fabiola Atzeni, Lorenzo Dagna, et al.
Pageof 40